Diagnostic and Interventional Cardiology

SimpleSense is an FDA cleared remote diagnostic platform. The cloth-based nanosensor technology undergarment monitors multiple patient vitals such as heart rate, blood pressure, respiration rate, and physical activity.

News | Cardiac Diagnostics

FDA Clears Nanowear Platform to Implement AI-based Home Diagnostics and Monitoring Network

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

October 04, 2021

The Abbott Amplatzer Talisman PFO Occlusion System is designed to treat people with a patent foramen ovale (PFO). The small opening between the upper chambers of the heart can increase the risk of recurrent ischemic stroke.

News | Structural Heart Occluders

FDA Clears Abbott Amplatzer Talisman PFO Occluder

October 4, 2021 — U.S. Food and Drug Administration (FDA) has cleared the Abbott Amplatzer Talisman PFO Occlusion System ...

October 04, 2021

The GE Healthcare Vsan Air wireless transducer point-of-care-ultrasound system will be used in combination with UltraSight artificial intelligence technology to monitor an astronaut's heart during Rakia space mission. The research will be used to determine the possible side effects of long-duration maned flights to Mars.

News | Cardiovascular Ultrasound

AI Enabled Wireless Cardiac Point-of-Care-Ultrasound Will be Used by Astronauts in Space

October 4, 2021 – UltraSight, a digital health company developing artificial intelligence (AI) enabled cardiac imaging ...

October 04, 2021

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

European Society of Cardiology 2021 Late-breaking hot-line Studies presented with links.

News | ESC | By Dave Fornell, DAIC Editor

European Society of Cardiology 2021 Late-breaking Studies

October 4, 2021 — Here are links to all the late-breaking cardiology studies presented in Hot-Line sessions at the 2021 ...

October 04, 2021

$A pooled analysis of two randomized trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction. The late breaking study is presented in a Hot Line at the European Society of Cardiology (ESC) 2021 Congress, and was published in the New England Journal of Medicine. Data from the EMPEROR-Preserved and in EMPEROR-Reduced trials.$

News | Heart Failure

Empagliflozin Benefits Heart Failure Patients With Reduced and Preserved Ejection Fraction

October 1, 2021 — A pooled analysis of two randomized trials has demonstrated the beneficial effects of empagliflozin in ...

October 04, 2021

Videos | Stem Cell Therapies

VIDEO: Engineered Heart Tissue Aids Research With a Heart in a Dish System

Mechanical engineering Professor Nathan Sniadecki, associate chair for research and infrastructure, mechanical ...

October 04, 2021

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

News | EP Lab

ESC Issues Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy

October 1, 2021 — The European Society of Cardiology (ESC) guidelines on cardiac pacing and cardiac resynchronization ...

October 04, 2021

News | Antiplatelet and Anticoagulation Therapies

MASTER DAPT Shows 1-month Dual Antiplatelet Therapy After Stent Benefits High Bleeding Risk Patients

October 4, 2021 — One month of dual antiplatelet therapy (DAPT) following stent implantation in high bleeding risk ...

October 04, 2021

A cardiac scan on the new Siemens Naeotom Alpha. This is the first commercialized photon-counting CT scanner. It gained FDA clearance Sept. 30, 2021. Image by Deutscher Zukunftpreis/Ansgar Pudenz.

Feature | Computed Tomography (CT) | By Dave Fornell, DAIC Editor

First Photon-counting CT System Cleared by the FDA

The U.S. Food and Drug Administration (FDA) Sept. 30 cleared the world's first photon-counting computed tomography (CT) ...

October 04, 2021

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Videos | EP Lab

VIDEO: Antibacterial Envelope for EP Devices Reduced Infections in Patients With Hemotomas by 82 Percent

Khaldoun Tarakji, M.D., MPH, associate section head, cardiac electrophysiology, Heart and Vascular Institute at ...

October 04, 2021

Gadolinium-enhanced MRI of a cardiac radiation therapy patient at baseline (left) and 3 months post-treatment (right). Top: the left ventricle with patchy, gadolinium-enhanced scar was transmurally targeted with a radiation ose of 25 Gy between 3 and 6 o’clock (red brackets). Nonenhanced, remote myocardium is adjacent to target region (white arrowhead). Bottom: surviving nonenhanced myocardium within the same images is visible in the targeted region at baseline and 3 months post-treatment (yellow outline).

Feature | EP Lab

Radiation Therapy Reprograms Heart Cells to Younger State

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

September 28, 2021

Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a personal medical device kit, Biokit, that includes a bundled of home-use devices to monitor cardiovascular disease. It includes a digital thermometer, a pulse oximeter and a blood pressure cuff. All three devices are U.S. FDA cleared, wireless, wearable, and integrate into the Biotricity ecosystem, a platform for interconnectivity.

News | Cardiac Diagnostics

Biotricity Releases Biokit With Three Home Monitoring Devices for Cardiac Disease Management

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

September 28, 2021

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Videos | Structural Heart

VIDEO: Roles of the Melody and Harmony Transcatheter Pulmonary Valves in Congenital Heart Disease

Tom Jones, M.D., director, cardiac cath labs, Seattle Children’s Hospital, and principle investigator of the Medtronic ...

September 28, 2021

CardioMEMS is a wireless, battery-free sensor that is implanted into the pulmonary artery via a right heart catheterization procedure to transmit pulmonary artery pressures.

News | Heart Failure

GUIDE-HF Trial Shows Hemodynamic Guided Management Benefits Larger Heart Failure Population

September 28, 2021 — Hemodynamic guided management using the CardioMEMS device may reduce heart failure hospitalizations ...

September 28, 2021

News | Coronavirus (COVID-19)

COVID Long-hauler Symptoms May be Caused by Antibody Attacks on ACE2

September 28, 2021 — A research team at the University of Arkansas for Medical Sciences (UAMS) has identified a ...

September 28, 2021